Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-239430
Filing Date
2021-08-06
Accepted
2021-08-06 17:18:05
Documents
4
Effectiveness Date
2021-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 d214404ds8.htm S-8 60432
2 EX-5.1 d214404dex51.htm EX-5.1 8571
3 EX-23.1 d214404dex231.htm EX-23.1 1413
4 GRAPHIC g214404g0804051207234.jpg GRAPHIC 2196
  Complete submission text file 0001193125-21-239430.txt   74809
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258595 | Film No.: 211153857
SIC: 3826 Laboratory Analytical Instruments